Showing results (51-60 of 295) with videos related to
Sort By:
Pageof 30
Life (Basel, Switzerland)|January 21, 2023
ALS-L1023 from <i>Melissa officinalis</i> Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease ModelEun Jeoung Lee, Yun Kim, Ji Eun Kim, et al.Scientific Reports|April 7, 2019
Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver DiseaseSang Bong Ahn, Dae Won Jun, Bo-Kyeong Kang, et al.Frontiers in Medicine|August 9, 2024
Barriers to care linkage and educational impact on unnecessary MASLD referralsJun-Hyuk Lee, Eileen Laurel Yoon, Ju Hyun Oh, et al.Frontiers in Immunology|February 28, 2022
Mass Cytometry Study on Hepatic Fibrosis and Its Drug-Induced Recovery Using Mouse Peripheral Blood Mononuclear CellsJiwon Bae, Ji Eun Kim, Haribalan Perumalsamy, et al.Journal of Clinical Medicine|September 14, 2019
Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort StudyJin Hwa Park, Jun Choi, Dae Won Jun, et al.Plos One|September 29, 2017
Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury?Waqar K Saeed, Dae Won Jun, Kiseok Jang, et al.Frontiers in Medicine|November 21, 2022
Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk populationHuiyul Park, Eileen L Yoon, Mimi Kim, et al.Journal of Hepatology|June 15, 2024
Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohortJoo Hyun Oh, Sang Bong Ahn, Seon Cho, et al.World Journal of Gastroenterology|November 3, 2018
Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosisYoung-Cheol Ju, Dae-Won Jun, Jun Choi, et al.Annals of Hepatology|January 8, 2013
Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the ratYi-Sun Song, Cheng-Hu Fang, Byung-Im So, et al.Pageof 30